Cimilactone ACAS# 468733-06-4 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 468733-06-4 | SDF | Download SDF |
| PubChem ID | 10908062 | Appearance | Powder |
| Formula | C33H50O9 | M.Wt | 590.74 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC1CC(=O)OC2C1C3(C(CC45CC46CCC(C(C6CCC5C3(C2)C)(C)C)OC7C(C(C(CO7)O)O)O)OC(=O)C)C | ||
| Standard InChIKey | RKTWPXXLEHCPIO-DWWJFHMPSA-N | ||
| Standard InChI | InChI=1S/C33H50O9/c1-16-11-24(36)41-19-12-30(5)21-8-7-20-29(3,4)22(42-28-27(38)26(37)18(35)14-39-28)9-10-32(20)15-33(21,32)13-23(40-17(2)34)31(30,6)25(16)19/h16,18-23,25-28,35,37-38H,7-15H2,1-6H3/t16-,18-,19+,20+,21+,22+,23-,25+,26+,27-,28+,30+,31-,32-,33+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cimilactone A shows significant anticomplement activity (IC(50)= 28.6 microm）. |
Cimilactone A Dilution Calculator
Cimilactone A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6928 mL | 8.464 mL | 16.9279 mL | 33.8558 mL | 42.3198 mL |
| 5 mM | 0.3386 mL | 1.6928 mL | 3.3856 mL | 6.7712 mL | 8.464 mL |
| 10 mM | 0.1693 mL | 0.8464 mL | 1.6928 mL | 3.3856 mL | 4.232 mL |
| 50 mM | 0.0339 mL | 0.1693 mL | 0.3386 mL | 0.6771 mL | 0.8464 mL |
| 100 mM | 0.0169 mL | 0.0846 mL | 0.1693 mL | 0.3386 mL | 0.4232 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 3-Benzofurancarboxaldehyde
Catalog No.:BCC8622
CAS No.:4687-25-6
- Dihydrocorynantheine
Catalog No.:BCN3747
CAS No.:4684-43-9
- Picrinine
Catalog No.:BCN5518
CAS No.:4684-32-6
- Norscopolamine
Catalog No.:BCN3983
CAS No.:4684-28-0
- Orphenadrine Citrate
Catalog No.:BCC4572
CAS No.:4682-36-4
- Drimenol
Catalog No.:BCN7224
CAS No.:468-68-8
- Mesembrenone
Catalog No.:BCN3753
CAS No.:468-54-2
- Lupulon
Catalog No.:BCC8204
CAS No.:468-28-0
- Colupulone
Catalog No.:BCN8097
CAS No.:468-27-9
- Lu AE58054
Catalog No.:BCC1707
CAS No.:467459-31-0
- Lu AE58054 Hydrochloride
Catalog No.:BCC1708
CAS No.:467458-02-2
- Nootkatone
Catalog No.:BCN5517
CAS No.:4674-50-4
- BMS-536924
Catalog No.:BCC1177
CAS No.:468740-43-4
- Hamamelitannin
Catalog No.:BCC8182
CAS No.:469-32-9
- Cycloeucalenol
Catalog No.:BCN5519
CAS No.:469-39-6
- Jervine
Catalog No.:BCN2975
CAS No.:469-59-0
- 5'-IMPdisodium salt
Catalog No.:BCN8175
CAS No.:4691-65-0
- Carbenicillin
Catalog No.:BCC5192
CAS No.:4697-36-3
- Uncarine D
Catalog No.:BCC8262
CAS No.:4697-68-1
- Isoalantolactone
Catalog No.:BCN4955
CAS No.:470-17-7
- Cinobufagin
Catalog No.:BCN5367
CAS No.:470-37-1
- Marinobufagin
Catalog No.:BCC9238
CAS No.:470-42-8
- Stachyose tetrahydrate
Catalog No.:BCC8252
CAS No.:470-55-3
- 1-Kestose
Catalog No.:BCN8292
CAS No.:470-69-9
Cimicifoetisides A and B, two cytotoxic cycloartane triterpenoid glycosides from the rhizomes of Cimicifuga foetida, inhibit proliferation of cancer cells.[Pubmed:17266751]
Beilstein J Org Chem. 2007 Jan 31;3:3.
Two new cycloartane-type triterpene glycosides, namely cimicifoetisides A (1) and B (2), along with seven known compounds cimigenol, 25-O-acetylcimigenol, cimigenol 3-O-beta-D-xylopyranoside, 12beta-hydroxycimigenol 3-O-beta-D-xylopyranoside, cimigenol 3-O-alpha-L-arabinopyranoside, 25-deoxyshengmanol 3-O-beta-D-xylopyranoside and Cimilactone A, were isolated from the rhizomes of Cimicifuga foetida. Their structures were elucidated as cimigenol 3-O-(2'-O-acetyl)-alpha-L-arabinopyranoside (1) and 25-O-acetylcimigenol 3-O-(2'-O-acetyl)-alpha-L-arabinopyranoside (2). Both compounds 1 and 2 exhibited potent cytotoxicity against rat EAC (Ehrlich ascites carcinoma) and MDA-MB-A231 (human breast cancer) cells with IC50 values of 0.52 and 6.74 microM for 1, and 0.19 and 10.21 microM for 2, suggesting their potential for further investigation as anti-cancer agents.
Anticomplement activity of cycloartane glycosides from the rhizome of Cimicifuga foetida.[Pubmed:16906637]
Phytother Res. 2006 Nov;20(11):945-8.
A tetranor-cycloartane glycoside and two 9,19-cycloartane glycosides were isolated from the EtOAc-soluble fraction of the rhizome of Cimicifuga foetida. The structures of the compounds were determined to be Cimilactone A (1), 25-O-acetylcimigenol 3-O-beta-d-xylopyranoside (2) and cimigenol 3-O-alpha-l-arabinopyranoside (3), respectively, using spectroscopic analysis. The three compounds were examined for their anticomplement activity against the classical pathway of the complement system. Compound 1 showed significant anticomplement activity with an IC(50) value of 28.6 microm, whereas compounds 2 and 3 were inactive.
